Personal Wearable Device for Tracking Air Pollution Exposure
Wearable Microsystem for Continuous Personalized Aerosol Exposure Assessment
This project aims to create a small, wearable device that continuously measures the air pollution you breathe, helping us understand your personal exposure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Michigan State University NIH-funded |
| Lab location | 1 site (East Lansing, United States) |
| Project ID | NIH-11118837 on NIH RePORTER |
What this research studies
This grant focuses on developing a tiny, wearable device that can continuously measure the air pollution you encounter throughout your day. The goal is to precisely identify the types and amounts of airborne particles you are exposed to, and when these exposures occur. By providing a detailed picture of personal air quality, this technology could help researchers create better strategies to protect people from harmful pollution. This work builds upon earlier efforts to develop wearable sensors for gaseous air pollutants.
Who could benefit from this research
Good fit: People concerned about their daily exposure to air pollution, especially those living in areas with poor air quality or with existing respiratory conditions, might be interested in future applications of this technology.
Not a fit: Patients whose health conditions are unrelated to environmental factors or who are not exposed to significant air pollution may not directly benefit from this specific technology.
Why it matters
Potential benefit: If successful, this technology could lead to personalized advice and interventions to reduce your exposure to harmful air pollutants, potentially improving your long-term health.
How similar studies have performed: While previous work has developed wearable sensors for gaseous pollutants, this project focuses on the novel development of wearable technology for continuous airborne particulate monitoring.
Where this research is happening
East Lansing, United States
- Michigan State University — East Lansing, United States (Active)
Researchers
- Principal investigator: Mason, Andrew J — Michigan State University
- Study coordinator: Mason, Andrew J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.